The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Johnson & Johnson (JNJ)     Sector: Healthcare  >  Industry: Major Drugs
Three Companies Present at Clear Vision Advisors Event

Jan 21, 2009 05:34 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

Three Companies Present at Clear Vision Advisors Event

Clear Vision Advisors successfully hosted its first networking event for the year last evening with three companies presenting and about 25 people in attendance. Below is more information on the three companies which presented at the event last evening, which are poised to benefit from several trends, including (1) the demand by an aging population for consumer healthcare products with fewer side effects than prescription treatments, (2) power management solutions for the energy infrastructure and metering market, and (3) more efficient data storage solutions.

ALCiS Health is a consumer healthcare company which develops innovative over-the-counter (OTC) topical treatments for pain relief under the ALCiS brand name. The OTC topical pain relief market is estimated at $800M, with leading brands such as Icy Hot – Chattem (CHTT), and Ben Gay – Johnson & Johnson (JNJ). The most recent successful product innovation is the ThermaCare heat wraps – Wyeth (WYE), which boast sales over $100M per year – the OTC equivalent of a blockbuster product, which is typically defined as $1B in sales for prescription drug treatments.

ALCiS has developed a unique drug delivery system for the active ingredient (Trolamine Salicylate 10%) which provides deep, penetrating pain relief in as little as five minutes. The Company's products are featured in more than 13,000 stores, including leading retailers and drugstores such as Walgreens (WAG), CVS Caremark (CVS), Rite Aid (RAD), Wal-Mart (WMT), Target (TGT), and many others.

POWRtec is an energy infrastructure management company which is expected to begin trading on the OTCBB next month with a market cap of about $32M with 10M shares outstanding at an opening price of $3.25 per share. POWRtec develops energy management solutions, including networked and broadband metering products. Pro forma revenue for 2009 is expected to come in at around $8.5M.

Competing companies listed for trading in the U.S. market include Echelon (ELON), Itron (ITRI), and ABB Ltd. (ABB). POWRtec's products include a built-in communication interface (WiFi, WiMAX, Ethernet, etc.) and real-time data with the ability to measure very low loads, allowing customers to bill at low load levels.

MultiXtor is a provider of flash memory storage in the form of FlashCard (PCI Express Card) and FlashBox (Server with several FlashCards) to compete with DRAM. Differentiating features include random I/O performance which is the same as sequential and write performance which is the same as read. The Company’s technology is designed to use memory more effectively, allowing for power savings and server consolidation through virtualization to reduce cap-ex spending for data centers.

Clear Vision Advisors was created to help guide companies, to aid in the acquisition of working capital and to provide the tools necessary for companies to realize their goals. Our experience as corporate insiders, provides our clients and client organizations with an outsider's perspective with a keen understanding of internal pressures.

Clear Vision Advisors
Burlingame, CA 94010
Phone: (650) 208-5804
Fax: (408) 516-8425
Email CVA


JNJ:  This call was made on 01/21/09 @ $55.77
Rating:   Positive   $55.77 (01/21/09)
Closed:   02/10/2009 @ $58.23 (+4.41% in 20 days)


Comments (2)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 414 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Arrow_up
Arrow_down
ink109   N/A     1 point   commented 346 days ago reply

Indeed, Gaskin’s outrage is palpable as she reports that stock marketonly six of the 50 states require hospitals to report deaths during childbirth to stock market todaythe Centers for Disease mortgage calculatorControl. Change is clearly needed. mortgage calculatorCan anyone concerned with perpetuating the human race possibly disagree?mortgage calculator


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Johnson & Johnson (JNJ)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.0%
Top:
64.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated JNJ
Positive +1.93% Epinex Diagnostics: A New Paradigm for Diabetic Testing
11/19/2009
9
Positive +5.70% BioMedReports: FDA Calendar Updates
07/15/2009
9
Positive +2.22% FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
07/13/2009
9
Positive +3.24% FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
05/20/2009
9
Positive -0.32% FDA Calendar Updates: ACUS, APPY, APPA, ALKS, JNJ
05/18/2009
9
Positive +9.22% FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
04/24/2009
9
Positive +0.10% Highly Defensive Index: Opportunities in Healthcare
04/13/2009
9
Positive -2.12% Updated Clinical Trial and FDA Decision Calendars
03/20/2009
9
Positive +4.49% Updated Clinical Trial and FDA Decision Calendars
03/17/2009
9
Positive +2.31% Cytori Therapeutics: A Natural Play on Cosmetic Medicine
03/01/2009
9
Positive -15.85% FDA Decision Calendar: Pain Drug Delays Likely
02/10/2009
9
Positive -5.76% FDA Calendar: Psoriasis Drug Delay is Minor for JNJ
12/20/2008
9
Positive +0.19% FDA Calendar: A Weekly Update
12/05/2008
9
Positive +2.86% A Coiled Spring: Near-Term Catalysts & Oversold Stocks
12/03/2008
9
Positive -0.40% Full Calendar of FDA Decisions
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/29/2008
9
Positive -2.63% A New Global Healthcare Composite Index
11/23/2008
9
Positive +0.00% Updated FDA Calendar of 73 Decision Dates
11/22/2008
9
Positive +7.26% Updated FDA Calendar of 75 Decision Dates
11/21/2008
9
Positive -9.49% ETFI Global Healthcare Sector PerformIdex
11/08/2008
9
Positive -0.80% Healthcare ETFs Outpace the Market
11/01/2008
9
Positive +0.79% Updated FDA Calendar of 72 Decision Dates
10/30/2008
9
Positive -2.15% Teva is on Target to Acquire Barr
10/29/2008
9
Positive +3.21% My 60 Defensive Growth Stock Picks at Inner8.com
10/25/2008
9
Positive -5.18% FDA Action Heats Up Before Year-End
10/21/2008
9
Positive +0.00% A Defensive Growth Stock Index
10/20/2008
9
Positive -7.06% Pfizer is a Big Pharma Buy
09/24/2008
3
Positive -4.03% Highly Defensive PerformIdex
08/10/2008
4
Positive +5.32% JNJ Is A Core Healthcare Holding
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch